Bradley E. Lerman - 05 Nov 2021 Form 4 Insider Report for Medtronic plc (MDT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Nov 2021, 17:01:45 UTC
Prior SEC filing
01 Oct 2021
Next SEC filing
26 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas L. Osteraas, attorney-in-fact

Key filing fact

Bradley E. Lerman filed Form 4 for Medtronic plc (MDT) on 09 Nov 2021.

Key facts

  • This page summarizes Bradley E. Lerman's Form 4 filing for Medtronic plc (MDT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Nov 2021, 17:01.

Change

  • Previous filing in this sequence was filed on 01 Oct 2021.
  • Current net transaction value: -$30,745.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Tax liability

Transaction value
$30,745
Shares
-250
Change %
-0.51%
Price
$122.98
Shares after
48,635
Date
05 Nov 2021
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This balance increased by 122 shares due to exempt transactions such as dividend reinvestment.

Footnote F2

The reported transaction involved the withholding of 250 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .